Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives.
Tordjman S, Najjar I, Bellissant E, Anderson GM, Barburoth M, Cohen D, Jaafari N, Schischmanoff O, Fagard R, Lagdas E, Kermarrec S, Ribardiere S, Botbol M, Fougerou C, Bronsard G, Vernay-Leconte J. Tordjman S, et al. Among authors: bellissant e. Int J Mol Sci. 2013 Oct 14;14(10):20508-42. doi: 10.3390/ijms141020508. Int J Mol Sci. 2013. PMID: 24129182 Free PMC article. Review.
Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder.
Lalanne S, Fougerou-Leurent C, Anderson GM, Schroder CM, Nir T, Chokron S, Delorme R, Claustrat B, Bellissant E, Kermarrec S, Franco P, Denis L, Tordjman S. Lalanne S, et al. Among authors: bellissant e. Int J Mol Sci. 2021 Feb 2;22(3):1490. doi: 10.3390/ijms22031490. Int J Mol Sci. 2021. PMID: 33540815 Free PMC article. Review.
Melatonin: Pharmacology, Functions and Therapeutic Benefits.
Tordjman S, Chokron S, Delorme R, Charrier A, Bellissant E, Jaafari N, Fougerou C. Tordjman S, et al. Among authors: bellissant e. Curr Neuropharmacol. 2017 Apr;15(3):434-443. doi: 10.2174/1570159X14666161228122115. Curr Neuropharmacol. 2017. PMID: 28503116 Free PMC article. Review.
Autism as a disorder of biological and behavioral rhythms: toward new therapeutic perspectives.
Tordjman S, Davlantis KS, Georgieff N, Geoffray MM, Speranza M, Anderson GM, Xavier J, Botbol M, Oriol C, Bellissant E, Vernay-Leconte J, Fougerou C, Hespel A, Tavenard A, Cohen D, Kermarrec S, Coulon N, Bonnot O, Dawson G. Tordjman S, et al. Among authors: bellissant e. Front Pediatr. 2015 Feb 23;3:1. doi: 10.3389/fped.2015.00001. eCollection 2015. Front Pediatr. 2015. PMID: 25756039 Free PMC article. Review.
Self-other recognition impairments in individuals with schizophrenia: a new experimental paradigm using a double mirror.
Keromnes G, Motillon T, Coulon N, Berthoz A, Du Boisgueheneuc F, Wehrmann M, Martin B, Thirioux B, Bonnot O, Ridereau R, Bellissant E, Drapier D, Levoyer D, Jaafari N, Tordjman S. Keromnes G, et al. Among authors: bellissant e. NPJ Schizophr. 2018 Nov 28;4(1):24. doi: 10.1038/s41537-018-0065-5. NPJ Schizophr. 2018. PMID: 30487540 Free PMC article.
Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study.
Roulot D, Thibault V, Laforest C, Fontaine H, Bronowicki JP, Asselah T, Bourlière M, Canva V, Leroy V, Loustaud-Ratti V, Ouzan D, Zoulim F, Schischmanoff O, Rousseau C, Renault A, Petrov-Sanchez V, Diallo A, Bellissant E, Serfaty L; ANRS HC32 QUATTRO study group. Roulot D, et al. Among authors: bellissant e. Eur J Gastroenterol Hepatol. 2018 Mar;30(3):302-309. doi: 10.1097/MEG.0000000000001035. Eur J Gastroenterol Hepatol. 2018. PMID: 29271782 Clinical Trial.
Use of very-high-dose olanzapine in treatment-resistant schizophrenia.
Batail JM, Langrée B, Robert G, Bleher S, Verdier MC, Bellissant E, Millet B, Drapier D. Batail JM, et al. Among authors: bellissant e. Schizophr Res. 2014 Nov;159(2-3):411-4. doi: 10.1016/j.schres.2014.09.020. Epub 2014 Sep 30. Schizophr Res. 2014. PMID: 25278103 Free article.
193 results